ROIV ROIVANT SCIENCES LTD Expansion Plans 8-K Filing 2024 - Revenue Growth Roivant Sciences Ltd reported a significant increase in revenue, reaching $100 million for the quarter, driven by strong sales of its new drug. The company also announced plans for further product expansion in the coming year.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD